Worsening Comorbidities

PATIENTS WITH HYPERCORTISOLISM HAVE AN INCREASED RISK FOR COMORBID CONDITIONS1,2

Document icon.

A systematic review and meta-analysis of 32 studies

Reported outcomes from 4121 patients (over a median of 4 years) with adrenal incidentalomas.1

Worsening type 2 diabetes (T2D) and hypertension1

Patients with hypercortisolism experienced worsening comorbidities compared to patients with nonfunctioning adenomas.

WORSENING Comorbid Conditions

Chart depicting worsening comorbid conditions in patients with hypercortisolism.
Document icon.

A 15-year, retrospective, single-center study analyzed 198 consecutive patients with adrenal adenomas.

Patients were grouped based on their dexamethasone suppression test (DST) cortisol levels at baseline and at study end.2

Increased risk of cardiovascular disease2

Patients with worsening DST ≥1.8 μg/dL had a 4x higher incidence of cardiovascular disease than those patients with DST <1.8 μg/dL

Cardiovascular Disease At Study End

Chart depicting cardiovascular disease at study end for patients with stable and worsening dexamethasone suppression test (DST).
Blood drop icon.

How to screen for hypercortisolism in patients with T2D

VIEW SCREENING
10% icon.

Up to 10% of patients with difficult-to-control T2D may have hypercortisolism3-5

UNCOVER PREVALENCE
Representative icon.

Contact a rep and stay informed

SIGN UP

References

1. Elhassan YS, Alahdab F, Prete A, et al. Ann Intern Med. 2019;171(2):107-116. doi:10.7326/M18-3630 2. Di Dalmazi G, Vivennati V, Garelli S, et al. Lancet Diabetes Endocrinol. 2014;2(5):396-405. doi:10.1016/S2213-8587(13)70211-0. 3. Chiodini I, Torlontano M, Scillitani A, et al. Eur J Endocrinol. 2005;153(6):837-844. doi:10.1530/eje.1.02045 4. Catargi B, Rigalleau V, Poussin A, et al. J Clin Endocrinol Metab. 2003;88(12):5808-5813. doi:10.1210/jc.2003-030254 5. Costa DS, Conceição FL, Leite NC, Ferreira MT, Salles GF, Cardoso CR. J Diabetes Complications. 2016;30(6):1032-1038. doi:10.1016/j.jdiacomp.2016.05.006